Here, gemcitabine-resistant pancreatic cancer cell lines and patient-derived xenograft (PDX) models are established, followed by high-throughput sequencing, which identified heterogeneous nuclear ribonucleoprotein C (HNRNPC) as a significantly upregulated factor in chemoresistant tumors. Here, HNRNPC is linked to pancreatic neoplasm.